Maintenance of Long-Term Safety and Efficacy of Cannabidiol Treatment in Dravet Syndrome: Results of the Open-Label Extension Trial (GWPCARE5)

被引：0
作者：
Devinsky, O. [1 ]
Nabbout, R. [2 ]
Miller, I. [3 ]
Laux, L. [4 ]
Zolnowska, M. [5 ]
Wright, S. [6 ]
Roberts, C. [6 ]
机构：
[1] NYU, Comprehens Epilepsy Ctr, New York, NY USA
[2] Necker Enfants Malad Hosp, Paris, France
[3] Miami Childrens Hosp, Miami, FL USA
[4] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA
[5] Ctr Med Plejady, Krakow, Poland
[6] GW Res Ltd, Cambridge, England
来源：
EPILEPSIA | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
p149
引用
收藏
页码：S73 / S73
页数：1
相关论文
共 50 条
[21]   Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan [J].
Inoue, Yushi ;
Ohtsuka, Yoko .
EPILEPSY RESEARCH, 2015, 113 :90-97
[22]   Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study [J].
Lai, Wyman W. ;
Galer, Bradley S. ;
Wong, Pierre C. ;
Farfel, Gail ;
Pringsheim, Milka ;
Keane, Martin G. ;
Agarwal, Anupam .
EPILEPSIA, 2020, 61 (11) :2386-2395
[23]   Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Treatment of Seizures Associated with Tuberous Sclerosis Complex (TSC) in an Open-Label Extension (OLE) Trial (GWPCARE6) [J].
Wheless, J. ;
Bebin, E. ;
Filloux, F. ;
Kwan, P. ;
Jansen, F. ;
Loftus, R. ;
Sahebkar, F. ;
Sparagana, S. ;
Thiele, E. .
ANNALS OF NEUROLOGY, 2021, 90 :S129-S130
[24]   Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Treatment of Seizures Associated with Tuberous Sclerosis Complex (TSC) in an Open-Label Extension (OLE) Trial (GWPCARE6) [J].
Wheless, James ;
Bebin, E. Martina ;
Filloux, Francis ;
Kwan, Patrick ;
Jansen, Floor E. ;
Loftus, Rachael ;
Sahebkar, Farhad ;
Sparagana, Steven ;
Thiele, Elizabeth .
NEUROLOGY, 2021, 96 (15)
[25]   Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia [J].
Kasper, S ;
Brecher, M ;
Fitton, L ;
Jones, AM .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) :281-289
[26]   Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial [J].
Thiele, Elizabeth A. ;
Bebin, E. Martina ;
Filloux, Francis ;
Kwan, Patrick ;
Loftus, Rachael ;
Sahebkar, Farhad ;
Sparagana, Steven ;
Wheless, James .
EPILEPSIA, 2022, 63 (02) :426-439
[27]   Long-term safety and efficacy of add-on cannabidiol for treatment of seizures associated with tuberous sclerosis complex in an open-label extension [J].
Kwan, Patrick ;
Thiele, Elizabeth A. ;
Bebin, E. Martina ;
Filloux, Francis ;
Jansen, Floor E. ;
Loftus, Rachael ;
Sahebkar, Farhad ;
Sparagana, Steven ;
Wheless, James .
EPILEPSIA, 2021, 62 :145-146
[28]   Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: An open-label extension trial [J].
McConville, B ;
Carrero, L ;
Sweitzer, D ;
Potter, L ;
Chaney, R ;
Foster, K ;
Sorter, M ;
Friedman, L ;
Browne, K .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (01) :75-82
[29]   Long-term safety and efficacy of clobazam for Lennox-Gastaut syndrome: Interim results of an open-label extension study [J].
Ng, Yu-Tze ;
Conry, Joan ;
Paolicchi, Juliann ;
Kernitsky, Lydia ;
Mitchell, Wendy ;
Drummond, Rebecca ;
Isojarvi, Jouko ;
Lee, Deborah ;
Owen, Randall .
EPILEPSY & BEHAVIOR, 2012, 25 (04) :687-694
[30]   ABP 501 Long-Term Safety/Efficacy: Interim Results from an Open-Label Extension Study [J].
Cohen, Stanley ;
Pablos, Jose L. ;
Zhang, Nan ;
Rizzo, Warren ;
Muller, Gerhard ;
Padmanaban, Devi ;
Kivitz, Alan ;
Matsumoto, Alan K. ;
Kaur, Primal .
ARTHRITIS & RHEUMATOLOGY, 2016, 68
12345